Zoledronic Acid Does Not Retard Bone Union: A Randomized Controlled Trial in Fragility Intertrochanteric Femur Fractures

Background: Fragility hip fracture is a leading cause of death in the elderly and is common in postmenopausal women and elderly people. In the treatment of osteoporosis, bisphosphonates (BPs) are often considered first-line medications. Zoledronic acid is the most potent and long-acting BP in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulia, Ankit, Das, Shakti Prasad, Sondur, Suhas, Rajendran, Preethiv, Mohanty, Anwesit, Prakash, Vishnu, Gutta, Hari, Pundhir, Hirdyanshu P, Rath, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Orthopedics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937685/
https://www.ncbi.nlm.nih.gov/pubmed/36819363
http://dx.doi.org/10.7759/cureus.33948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937685/
https://www.ncbi.nlm.nih.gov/pubmed/36819363
http://dx.doi.org/10.7759/cureus.33948

Ejemplares similares